Evaluation of Gastric Juice Samples During Standard Gastroscopy Procedure
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01267318
(Sponsor decided to terminate the entire project, and therefore there was no use for the samples collected in the study.)
Development of a new diagnostic detection tool for gastrointestinal bleeding.
Condition or disease
Literature does not support enough data/knowledge regarding stomach bleeding Hb levels in pathological situations and/or stomach bleeding levels following biopsy. It is important to understand the approximate concentration level of stomach bleeding before proceeding with technology development to insure this technology is capable of detecting such blood levels.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
All gastric juice samples should contain blood. This will be determined by the treating physician based on visual assessment in a region alongside the fresh biopsy site just performed, and prior to any saline washing.
Male or female subjects ≥ 18 years old.
Subject is scheduled for EGD endoscopy which includes biopsy, or,
Subject is scheduled for EGD endoscopy following a bleeding event.
Subject is either not competent or not willing to provide written informed consent.